1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Pharmarise Holdings Corporation

Pharmarise Holdings Corporation

2796.T
Pharmarise Holdings CorporationJP flagTokyo Stock Exchange
484.00
JPY
+4.00
- -
5.57BMarket Cap

Total Valuation

Pharmarise Holdings Corporation carries a market capitalization of 5.57B, placing it among publicly traded companies globally. Its enterprise value stands at 11.76B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.57B
Enterprise Value11.76B

Share Statistics

Pharmarise Holdings Corporation currently has 11.24M shares outstanding.

Shares Outstanding11.24M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Pharmarise Holdings Corporation trades at a trailing price-to-earnings ratio of 12.31. The price-to-sales ratio is 0.11, and the price-to-book ratio stands at 1.11.

PE Ratio12.31
PS Ratio0.11
PB Ratio1.11
P/TBV Ratio5.94
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Pharmarise Holdings Corporation trades at an EV/EBITDA multiple of 12.83 and an EV/FCF ratio of 950.23. The EV/Sales ratio of 0.22 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.83 provides insight into valuation relative to core operating earnings.

EV / Sales0.22
EV / EBITDA12.83
EV / EBIT12.83
EV / FCF950.23

Financial Position

Pharmarise Holdings Corporation maintains a current ratio of 1.29, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 171.36, indicating elevated leverage, while an interest coverage ratio of 13.88 demonstrates strong ability to service its debt obligations.

Current Ratio1.29
Quick Ratio0.67
Debt / Equity171.36
Debt / EBITDA13.92
Interest Coverage13.88

Financial Efficiency

Pharmarise Holdings Corporation posts a return on equity of -6.50 and a return on invested capital of -11.93.

Return on Equity (ROE)-6.50
Return on Assets (ROA)-1.33
Return on Invested Capital (ROIC)-11.93
Return on Capital Employed (ROCE)-3.16
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover18.65

Taxes

Over the trailing twelve months, Pharmarise Holdings Corporation has paid 487.00M in income taxes, reflecting an effective tax rate of 340.56.

Income Tax487.00M
Effective Tax Rate340.56

Stock Price Statistics

Pharmarise Holdings Corporation's stock has declined approximately -2.41935% over the past 52 weeks. The 50-day moving average sits at 510.90, while the 200-day moving average is 519.09.

Beta (5Y)N/A
52-Week Price Change-2.41935%
50-Day Moving Average510.90
200-Day Moving Average519.09
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Pharmarise Holdings Corporation generated 54.47B in revenue and converted that into -351.00M in net income, yielding earnings per share of -36.50. EBITDA reached 916.00M, while operating income came in at 916.00M.

Revenue54.47B
Gross Profit8.45B
Operating Income916.00M
Pretax Income143.00M
Net Income-351.00M
EBITDA916.00M
EBIT916.00M
Earnings Per Share (EPS)-36.50

Balance Sheet

Pharmarise Holdings Corporation holds 7.15B in cash and equivalents against 12.75B in total debt, resulting in a net debt position of 5.16B. Total book value stands at 5.49B, with working capital of 3.05B providing operational flexibility.

Cash & Cash Equivalents7.15B
Total Debt12.75B
Net Debt5.16B
Equity (Book Value)5.49B
Book Value Per Share582.57
Working Capital3.05B

Margins

Pharmarise Holdings Corporation operates with a gross margin of 15.51, reflecting its pricing power and cost economics. The operating margin of 1.68 and net profit margin of -0.64 provide insight into operational efficiency.

Gross Margin15.51
Operating Margin1.68
Pretax Margin0.26
Profit Margin-0.64
EBITDA Margin1.68

Stock Splits

Pharmarise Holdings Corporation's most recent stock split took place on November 27, 2013 with a 1:100 split ratio.

Last Split Date11/27/2013
Split Ratio1:100

Scores

Pharmarise Holdings Corporation posts an Altman Z-Score of 3.03, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.03